CLASS II ONGOING Drug recall · Reported 28 Oct 2026 · FDA Enforcement Report
Testosterone Cypionate, 200 mg/mL recalled by Right Value Drug Stores
Right Value Drug Stores is recalling Testosterone Cypionate, 200 mg/mL, distributed nationwide in the US. The recall was initiated on 9 Oct 2026 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0070-2027
- FDA event ID
- 100109
- Recalling firm
- Right Value Drug Stores, Irving, TX
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 9 Oct 2026
- FDA classified
- 19 Oct 2026
- Reported
- 28 Oct 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 9 Oct 2026 | Recall initiated by company | |
| 19 Oct 2026 | Classified by FDA | +10 days |
| 28 Oct 2026 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of sterility assurance.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Testosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials (NDC 73271-1225-1) and b) 30 m vials ( NDC 73271-1226-2) This Is A Compounded Dug, Intramuscular Use, Office Use Only, 8400 Esters Blvd, STE 190, Irving, TX 75063.
Where it was distributed
Nationwide in the USA.
Questions about this recall
Why was it recalled?
Lack of sterility assurance.
Which lots are affected?
a) Lot 10212025@3, BUD 10/21/2026; 10292025@4, BUD 10/29/2026; 10282025@6, BUD: 10/29/2026; 12012025@1, BUD: 12/01/2026; 04072026@1, BUD: 04/01/2027; 05262026@3, BUD 05/08/2027; 05262026@7, BUD 11/17/2026; 05272026@1, BUD 05/08/2027; 05272026@2, BUD: 11/22/2026; 07032026@1, BUD 05/08/2027; 07022026@1, BUD: 05/08/2027; 07062026@3, BUD: 05/08/2027; 07072026@3, BUD: 12/30/2026. b) 04012026@2, BUD 04/01/2027.
Where was it sold?
Nationwide in the USA.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 3 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Right Value Drug Stores
All 8| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine recalled | Right Value Drug Stores | Packaging Defects | Nationwide |
| Drug | CLASS III | Progesterone SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Tadalafil SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Progesterone SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
| Drug | CLASS III | Tadalafil SR recalled by Right Value Drug Stores | Right Value Drug Stores | Labeling Errors | CA |
Other Testosterone Cypionate recalls
All 131| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Testosterone Cypionate Injection, 200 mg/mL, CIII recalled | Empower Clinic Services | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200 mg/mL recalledTestosterone Cypionate | Azurity Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Enanthate 100/100mg/ml, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |